Industry News

Lannett to acquire Silarx Pharmaceuticals

Centerwatch - Wed, 2015-05-20 11:17
Lannett, a Philadelphia, Pa.-based developer and marketer of generic pharmaceutical products, has signed a definitive agreement to acquire privately held, New York-based Silarx Pharmaceuticals and a related real estate entity, a manufacturer and marketer of liquid generic pharmaceutical products. The transaction is expected to close in early June, subject to customary closing conditions. Strategic benefits of the acquisition include an FDA-approved manufacturing facility, research R&D experience and added diversity to Lannett’s portfolio of existing and pipeline products.  
Categories: Industry News

Forum Pharmaceuticals relocates headquarters to Waltham, Massachusetts

Centerwatch - Wed, 2015-05-20 11:15
Forum Pharmaceuticals, a biopharmaceutical company focused on the development and delivery of innovative medicines to treat serious brain diseases, has relocated its corporate headquarters to a 112,500-square-foot, state-of-the-art facility located in Waltham, Mass. The move consolidates Forum’s operations into a single centralized location that houses corporate offices, clinical development and research laboratories. Previously, Forum conducted business from two locations in Watertown, Mass. and Brighton, Mass. The company also maintains a small European office in the Netherlands.
Categories: Industry News

Janssen, Rutgers School of Engineering expand collaboration

Centerwatch - Wed, 2015-05-20 11:13
Janssen Supply Chain has expanded its partnership with the Rutgers University School of Engineering by providing over $6 million to expand ongoing research efforts supporting the company’s introduction of continuous manufacturing techniques for pharmaceuticals.
Categories: Industry News

Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease

sleep - Tue, 2015-05-19 20:00
Status: Active, not recruiting, Condition Summary: Parkinson Disease; Sleep Disorders
Categories: Industry News

Sleep Disorders in Pediatric Dialysis

sleep - Tue, 2015-05-19 20:00
Status: Completed, Condition Summary: Chronic Kidney Disease (CKD)
Categories: Industry News

FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood

FDA News - Tue, 2015-05-19 07:11
The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization.
Categories: Industry News

Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease

Alzheimers - Mon, 2015-05-18 20:00
Status: Completed, Condition Summary: Alzheimer's Disease
Categories: Industry News

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Alzheimers - Mon, 2015-05-18 20:00
Status: Completed, Condition Summary: Alzheimer Disease
Categories: Industry News

CluePoints announces U.S patent allowance for SMART Engine

Centerwatch - Mon, 2015-05-18 10:33
CluePoints, a provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has announced that the U.S. Patent and Trademark Office has granted a Notice of Allowance for Application No. 13/452,338, a patent which covers the company's SMART engine. The patent provides broad coverage for CluePoints' proprietary methodology that supports a risk-based approach to data monitoring in clinical trials.
Categories: Industry News

Quintiles VP Dr. Judith Beach joins ACRES board of directors

Centerwatch - Mon, 2015-05-18 10:23
The Alliance for Clinical Research Excellence and Safety (ACRES) has added Dr. Judith Beach, senior vice president and senior associate general counsel for regulatory affairs at Quintiles, to its board of directors. Beach brings her wide-ranging experience in legal and regulatory counsel on international and domestic regulatory issues in the pharmaceutical, medical device and biotechnology industries, as well as her chief privacy officer responsibilities, to ACRES mission of building a global system for accountable clinical research.
Categories: Industry News

Endo to acquire Par Pharmaceutical for $8 billion

Centerwatch - Mon, 2015-05-18 09:06
Ireland-based Endo International has agreed to acquire privately held, Woodcliff Lake, N.J.-based Par Pharmaceutical from TPG for $8.05 billion, including assumption of Par debt. The transaction has been unanimously approved by the boards of directors of both Endo and Par and is supported by the management teams of both companies. There are no further shareholder approvals required.
Categories: Industry News

Redx Pharma launches third subsidiary, Redx Immunology

Centerwatch - Mon, 2015-05-18 09:05
Redx Pharma has launched its third subsidiary, Redx Immunology, which will focus on developing new therapies for disorders of the immune system.
Categories: Industry News

Human Longevity, Cleveland Clinic collaborate on human genomics

Centerwatch - Mon, 2015-05-18 09:04
Human Longevity (HLI), a San Diego-based, privately held company building a comprehensive database of human genotypes and phenotypes, and the Cleveland Clinic, a nonprofit multispecialty academic medical center, have inked a broad collaboration agreement to first sequence and analyze blood samples from Cleveland Clinic's GeneBank study of de-identified patients.
Categories: Industry News

Circassia to acquire Aerocrine and Prosonix

Centerwatch - Mon, 2015-05-18 09:03
Circassia Pharmaceuticals has made an all cash offer to acquire Aerocrine, a Swedish company focused on the development and commercialization of medical diagnostic products for use in the diagnosis and management of patients with asthma, for up to $216.4 million.
Categories: Industry News

OMT Therapeutics, Caltech ink UniRat alliance

Centerwatch - Mon, 2015-05-18 09:01
The California Institute of Technology (Caltech) has partnered with OMT Therapeutics, a private, California-based biotech company, to use OMT Therapeutics’ fully human nanobody platform, UniRat, for the generation of nanobodies against HIV-1.
Categories: Industry News

Genzyme, Ablynx collaborate on multiple sclerosis research project

Centerwatch - Mon, 2015-05-18 08:58
Ablynx, a biopharma company headquartered in Belguim, has entered into an exclusive research collaboration with Genzyme, a Sanofi company, to investigate nanobodies against a multiple sclerosis (MS) target specifically aligning with Genzyme's early-stage MS research programs involving neuroprotection and CNS repair.
Categories: Industry News

Build a web site for your clinical trial

Centerwatch - Mon, 2015-05-18 04:00
Technology has amazing potential in clinical research, although often it is met with reluctance, resulting in slower adoption.
Categories: Industry News

Inactive Ingredients Database Download

FDA News - Fri, 2015-05-15 13:52
Data updated through September 16, 2013.
Categories: Industry News

Additions/Deletions for Prescription and OTC Drug Product Lists

FDA News - Fri, 2015-05-15 11:45
The list has been updated through April 2015.
Categories: Industry News

DAC Patient Recruitment Services takes home gold in the 2015 Hermes Creative Awards

Centerwatch - Fri, 2015-05-15 10:36
DAC Patient Recruitment Services, a patient recruitment and retention for global clinical trials company, earned a Gold Award in the 2015 Hermes Creative Awards. Hermes awards are presented to those entries judged to exceed the high standards of the industry norm.
Categories: Industry News
Syndicate content